132 related articles for article (PubMed ID: 9223163)
21. Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children.
Drakeley CJ; Eling W; Teelen K; Bousema JT; Sauerwein R; Greenwood BM; Targett GA
Parasite Immunol; 2004 Apr; 26(4):159-65. PubMed ID: 15367293
[TBL] [Abstract][Full Text] [Related]
22. Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera.
van der Kolk M; de Vlas SJ; Sauerwein RW
Int J Parasitol; 2006 Sep; 36(10-11):1091-5. PubMed ID: 16790244
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum.
Roeffen WF; Raats JM; Teelen K; Hoet RM; Eling WM; van Venrooij WJ; Sauerwein RW
J Biol Chem; 2001 Jun; 276(23):19807-11. PubMed ID: 11279092
[TBL] [Abstract][Full Text] [Related]
24. Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332.
Ahlborg N; Flyg BW; Iqbal J; Perlmann P; Berzins K
Parasite Immunol; 1993 Jul; 15(7):391-400. PubMed ID: 7692377
[TBL] [Abstract][Full Text] [Related]
25. Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia.
Bousema JT; Roeffen W; van der Kolk M; de Vlas SJ; van de Vegte-Bolmer M; Bangs MJ; Teelen K; Kurniawan L; Maguire JD; Baird JK; Sauerwein RW
Am J Trop Med Hyg; 2006 Mar; 74(3):425-31. PubMed ID: 16525101
[TBL] [Abstract][Full Text] [Related]
26. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
27. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.
Theisen M; Jore MM; Sauerwein R
Expert Rev Vaccines; 2017 Apr; 16(4):329-336. PubMed ID: 28043178
[TBL] [Abstract][Full Text] [Related]
28. A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies.
Singh SK; Roeffen W; Andersen G; Bousema T; Christiansen M; Sauerwein R; Theisen M
Vaccine; 2015 Apr; 33(16):1981-6. PubMed ID: 25728318
[TBL] [Abstract][Full Text] [Related]
29. Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate.
Drakeley CJ; Duraisingh MT; Póvoa M; Conway DJ; Targett GA; Baker DA
Mol Biochem Parasitol; 1996 Oct; 81(2):253-7. PubMed ID: 8898341
[No Abstract] [Full Text] [Related]
30. Role of heat-labile serum factor or host complement in the inhibition of Plasmodium falciparum sporogonic stages in Anopheles stephensi by gametocyte carriers' serological factors.
Gouagna LC; van der Kolk M; Roeffen W; Verhave JP; Eling W; Sauerwein R; Boudin C
Parasitology; 2007 Sep; 134(Pt 10):1315-27. PubMed ID: 17645813
[TBL] [Abstract][Full Text] [Related]
31. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses to Plasmodium falciparum gametocyte antigens during and after malaria attacks in schoolchildren from Madang, Papua New Guinea.
Graves PM; Doubrovsky A; Beckers P
Parasite Immunol; 1991 May; 13(3):291-9. PubMed ID: 1712931
[TBL] [Abstract][Full Text] [Related]
33. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam.
Wang L; Richie TL; Stowers A; Nhan DH; Coppel RL
Infect Immun; 2001 Jul; 69(7):4390-7. PubMed ID: 11401978
[TBL] [Abstract][Full Text] [Related]
34. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
[TBL] [Abstract][Full Text] [Related]
35. Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.
Eldering M; Bompard A; Miura K; Stone W; Morlais I; Cohuet A; van Gemert GJ; Brock PM; Rijpma SR; van de Vegte-Bolmer M; Graumans W; Siebelink-Stoter R; Da DF; Long CA; Morin MJ; Sauerwein RW; Churcher TS; Bousema T
Parasit Vectors; 2017 Oct; 10(1):489. PubMed ID: 29041962
[TBL] [Abstract][Full Text] [Related]
36. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers.
Drakeley CJ; Bousema JT; Akim NI; Teelen K; Roeffen W; Lensen AH; Bolmer M; Eling W; Sauerwein RW
Parasite Immunol; 2006 May; 28(5):185-90. PubMed ID: 16629703
[TBL] [Abstract][Full Text] [Related]
37. Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.
Datta D; Bansal GP; Grasperge B; Martin DS; Philipp M; Gerloff D; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2017 Dec; 35(50):7049-7056. PubMed ID: 29132995
[TBL] [Abstract][Full Text] [Related]
38. A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages.
Theisen M; Roeffen W; Singh SK; Andersen G; Amoah L; van de Vegte-Bolmer M; Arens T; Tiendrebeogo RW; Jones S; Bousema T; Adu B; Dziegiel MH; Christiansen M; Sauerwein R
Vaccine; 2014 May; 32(22):2623-30. PubMed ID: 24662702
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
